Nearly sixty years after an underground educator published a $1 mail-order booklet on how to avoid bad LSD trips, contemporary psychedelic users and facilitators still endorse almost all of her practical advice. A new survey study published in Psychedelics indicates that experienced users agreed on average with 18 out of 19 safety recommendations from Lisa Bieberman’s 1967 manual, suggesting that much of today’s harm reduction advice was already circulating in grassroots literature decades before modern clinical guidelines.
Psychedelics are mind-altering substances, such as psilocybin (the active compound in “magic mushrooms”) and lysergic acid diethylamide (LSD), that temporarily produce profound shifts in perception, emotion, and thought. Psychedelic harm reduction refers to practical strategies aimed at lowering the psychological and physical risks of taking these drugs, rather than relying solely on abstinence. In practice, harm reduction focuses on preparing one’s mindset beforehand, arranging a calm and secure physical environment, and ensuring reliable emotional support during a session.
Growing public interest in clinical trials of psychedelic-assisted therapy has coincided with rising psychedelic use in the general population, most of which still occurs outside supervised medical settings. Although classic psychedelics carry relatively low risks of organ toxicity or addiction compared to many legal and pharmaceutical drugs, unsupervised trips can provoke acute panic, paranoia, confusion, and, in rarer instances, cardiovascular strain or severe psychiatric episodes.
Difficult reactions can also linger long after the drug wears off. In an earlier study of people who experienced extended difficulties after taking psychedelics, persistent anxiety and fear were the most common post-trip challenges, reported by 67 percent of respondents, and taking substances without a guide was associated with a wider range of lasting problems.
Source: PsyPost — Read the full article on the original site ↗